Influenza virus split vaccine

BIOLOGICAL3 trials

Sponsors

Jiangsu Province Centers for Disease Control and Prevention, Shanghai Institute Of Biological Products

Conditions

Influenza

Phase 1

A Clinical Trial of an Quadrivalent Inactivated Influenza Vaccine in Healthy Children Aged 6 to 35 Months

CompletedNCT05212623

Jiangsu Province Centers for Disease Control and PreventionInfluenza

Start: 2021-10-26End: 2022-06-16Updated: 2022-10-28

A Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above

RecruitingNCT07302256

Shanghai Institute Of Biological ProductsInfluenza

Start: 2025-12-16End: 2026-08-31Target: 120Updated: 2026-01-14

Phase 2

Phase Ⅱ Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above

Not yet recruitingNCT07327398

Shanghai Institute Of Biological ProductsInfluenza

Start: 2026-01-07End: 2026-09-30Target: 1200Updated: 2026-01-15